Passage Bio, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2018 | — | — | $24.9M |
| Mar 2019 | — | — | $43.9M |
| Jun 2019 | — | — | $78.8M |
| Sep 2019 | — | — | $177.2M |
| Dec 2019 | $4.3M | $178.6M | $158.9M |
| Mar 2020 | $5.8M | $392.4M | $366.8M |
| Jun 2020 | $14.7M | $378.1M | $353.4M |
| Sep 2020 | $19.8M | $358.7M | $200.6M |
| Dec 2020 | $23.3M | $328.0M | $135.0M |
| Mar 2021 | $23.7M | $465.2M | $249.5M |
| Jun 2021 | $37.3M | $439.5M | $215.5M |
| Sep 2021 | $28.7M | $390.9M | $162.9M |
| Dec 2021 | $36.4M | $355.1M | $129.0M |
| Mar 2022 | $51.9M | $333.2M | $101.6M |
| Jun 2022 | $51.4M | $299.4M | $91.1M |
| Sep 2022 | $45.7M | $270.1M | $62.6M |
| Dec 2022 | $42.2M | $243.5M | $34.6M |
| Mar 2023 | $42.9M | $213.2M | $33.4M |
| Jun 2023 | $43.3M | $193.7M | $30.3M |
| Sep 2023 | $43.0M | $169.3M | $33.6M |
| Dec 2023 | $39.3M | $150.5M | $21.7M |
| Mar 2024 | $35.6M | $140.5M | $36.8M |
| Jun 2024 | $34.8M | $125.4M | $24.8M |
| Sep 2024 | $39.0M | $111.8M | $32.3M |
| Dec 2024 | $41.2M | $102.4M | $37.6M |
| Mar 2025 | $39.3M | $86.0M | $63.4M |
| Jun 2025 | $40.9M | $79.2M | $57.6M |
| Sep 2025 | $43.0M | $74.2M | $52.8M |
| Dec 2025 | $43.5M | $62.3M | $46.3M |
| Mar 2026 | $24.7M | $36.5M | $33.3M |
| Jun 2026 | $20.7M | $25.2M | $24.2M |